聚[6-[4-(4-氰基苯基)苯氧基]己基甲基丙烯酸酯] → 4,4'-[(2-Oxoimidazolin-1,3-diyl)bis(methylene)]-bis(benzonitrile)

HRID 2722

反应方程式

HRID 2722 反应方程式
[H-].[Na+].[NH:3]1[CH2:7][CH2:6][NH:5][C:4]1=[O:8].Br[CH2:10][C:11]1[CH:18]=[CH:17][C:14]([C:15]#[N:16])=[CH:13][CH:12]=1.O>CN(C)C=O>[O:8]=[C:4]1[N:5]([CH2:10][C:11]2[CH:18]=[CH:17][C:14]([C:15]#[N:16])=[CH:13][CH:12]=2)[CH2:6][CH2:7][N:3]1[CH2:10][C:11]1[CH:18]=[CH:17][C:14]([C:15]#[N:16])=[CH:13][CH:12]=1

参与物

6

反应物 4

HCID 962聚[6-[4-(4-氰基苯基)苯氧基]己基甲基丙烯酸酯]HCID 84532-咪唑烷酮HCID 24758氢化钠HCID 869964-氰基溴苄

产物 1

HCID 700916594,4'-[(2-Oxoimidazolin-1,3-diyl)bis(methylene)]-bis(benzonitrile)

试剂、催化剂与溶剂 1

HCID 6228N,N-二甲基甲酰胺溶剂

实验过程

To sodium hydride (2.4 g, 60 mmol) in dimethylformamide (50 mL) at 0° C. was added imidazolin-2-one (2.6 g, 30 mmol). After stirring for 20 minutes 4-(bromomethyl)benzonitrile (13 g, 66 mmol) was added and the mixture was warmed to ambient temperature. After stirring for 1 hour the reaction was poured into water and a solid formed. The solid was filtered to give 4,4'-[(2-oxoimidazolin-1,3-diyl)bis(methylene)]-bis(benzonitrile). NMR (CDCl3) 7.65 (d,4), 7.4 (d,4), 4.45 (s,4), 3.2 (s,4) ppm.

后处理

  1. additionwas added
  2. customa solid formed
  3. filtrationThe solid was filtered

来源与证据

ORD记录
ord-6f8a65c0c7a247018b76537d1c75a375
来源数据集
uspto-grants-1998_03
专利号
US05731311

关联笔记

加载中…